Q1 2022 13F Holders as of 3/31/2022
-
Type / Class
-
Equity / Common Stock, par value $0.001 per share
-
Shares outstanding
-
65.9M
-
Number of holders
-
77
-
Total 13F shares, excl. options
-
15.3M
-
Shares change
-
+224K
-
Total reported value, excl. options
-
$48.9M
-
Value change
-
+$170K
-
Put/Call ratio
-
0
-
Number of buys
-
31
-
Number of sells
-
-40
-
Price
-
$3.19
Significant Holders of Cytosorbents Corp - Common Stock, par value $0.001 per share (CTSO) as of Q1 2022
96 filings reported holding CTSO - Cytosorbents Corp - Common Stock, par value $0.001 per share as of Q1 2022.
Cytosorbents Corp - Common Stock, par value $0.001 per share (CTSO) has 77 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 15.3M shares
of 65.9M outstanding shares and own 23.29% of the company stock.
Largest 10 shareholders include VANGUARD GROUP INC (2.19M shares), AVENIR CORP (2.18M shares), Skylands Capital, LLC (2.13M shares), Neuberger Berman Group LLC (1.25M shares), Granahan Investment Management, LLC (1.22M shares), Sargent Investment Group, LLC (827K shares), STATE STREET CORP (723K shares), GEODE CAPITAL MANAGEMENT, LLC (703K shares), NORTHERN TRUST CORP (362K shares), and CM Management, LLC (350K shares).
This table shows the top 77 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.